HER2+ breast cancer patients live longer if drugs given before surgery eradicate tumour
Final analysis of results from a randomised clinical trial of lapatinib and trastuzumab given before surgery in patients with early HER2-positive breast cancer has found that women who had no signs of residual disease after ...
Oct 2, 2020